CA3100633A1 - Nanovecteurs biodegradables (materiau organosilicie mesoporeux periodique biodegradable) pour therapie par capture de neutrons et procedes connexes - Google Patents

Nanovecteurs biodegradables (materiau organosilicie mesoporeux periodique biodegradable) pour therapie par capture de neutrons et procedes connexes Download PDF

Info

Publication number
CA3100633A1
CA3100633A1 CA3100633A CA3100633A CA3100633A1 CA 3100633 A1 CA3100633 A1 CA 3100633A1 CA 3100633 A CA3100633 A CA 3100633A CA 3100633 A CA3100633 A CA 3100633A CA 3100633 A1 CA3100633 A1 CA 3100633A1
Authority
CA
Canada
Prior art keywords
neutron capture
composition
bpmo
capture agent
isotope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3100633A
Other languages
English (en)
Inventor
Fuhuhiko Tamanoi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TAE Life Sciences LLC
Original Assignee
TAE Life Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TAE Life Sciences LLC filed Critical TAE Life Sciences LLC
Priority to CA3100633A priority Critical patent/CA3100633A1/fr
Publication of CA3100633A1 publication Critical patent/CA3100633A1/fr
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3100633A 2020-11-25 2020-11-25 Nanovecteurs biodegradables (materiau organosilicie mesoporeux periodique biodegradable) pour therapie par capture de neutrons et procedes connexes Pending CA3100633A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3100633A CA3100633A1 (fr) 2020-11-25 2020-11-25 Nanovecteurs biodegradables (materiau organosilicie mesoporeux periodique biodegradable) pour therapie par capture de neutrons et procedes connexes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA3100633A CA3100633A1 (fr) 2020-11-25 2020-11-25 Nanovecteurs biodegradables (materiau organosilicie mesoporeux periodique biodegradable) pour therapie par capture de neutrons et procedes connexes

Publications (1)

Publication Number Publication Date
CA3100633A1 true CA3100633A1 (fr) 2022-05-25

Family

ID=81751035

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3100633A Pending CA3100633A1 (fr) 2020-11-25 2020-11-25 Nanovecteurs biodegradables (materiau organosilicie mesoporeux periodique biodegradable) pour therapie par capture de neutrons et procedes connexes

Country Status (1)

Country Link
CA (1) CA3100633A1 (fr)

Similar Documents

Publication Publication Date Title
Ning et al. Type-I AIE photosensitizer loaded biomimetic system boosting cuproptosis to inhibit breast cancer metastasis and rechallenge
Pan et al. Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection
Bian et al. Review of functionalized nanomaterials for photothermal therapy of cancers
Zhong et al. Copper‐based nanomaterials for cancer theranostics
Li et al. Red blood cell membrane-enveloped O2 self-supplementing biomimetic nanoparticles for tumor imaging-guided enhanced sonodynamic therapy
Sadiq et al. A critical review on metal-organic frameworks (MOFs) based nanomaterials for biomedical applications: Designing, recent trends, challenges, and prospects
Jin et al. Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges
Fan et al. Biodistribution, degradability and clearance of 2D materials for their biomedical applications
Zhang et al. X-ray-triggered NO-released Bi–SNO nanoparticles: all-in-one nano-radiosensitizer with photothermal/gas therapy for enhanced radiotherapy
Yang et al. Rod-shape MSN@ MoS2 nanoplatform for FL/MSOT/CT imaging-guided photothermal and photodynamic therapy
JP6042450B2 (ja) 金属材料および酸化ハフニウム材料を含むナノ粒子、その製造および使用
Allard et al. 188Re-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomas
Liu et al. Ultrafast synthesizing bismuth mesoporous nanolitchi radiosensitizer loading high dose DOX for CT-guided enhanced chemoradiotherapy
Jiang et al. Radiodynamic therapy with CsI (na)@ MgO nanoparticles and 5-aminolevulinic acid
US20220080046A1 (en) Methods of Performing Neutron Capture Therapy
Yue et al. Advances of nanotechnology applied to cancer stem cells
Li et al. Tantalum-carbon-integrated nanozymes as a nano-radiosensitizer for radiotherapy enhancement
CN106512027A (zh) 四氧化三铁/壳聚糖/吲哚菁绿复合粒子及其制备与应用
Wang et al. α-Fe2O3@ Au-PEG-Ce6-Gd nanoparticles as acidic H2O2-driven oxygenators for multimodal imaging and synergistic tumor therapy
CA3100633A1 (fr) Nanovecteurs biodegradables (materiau organosilicie mesoporeux periodique biodegradable) pour therapie par capture de neutrons et procedes connexes
JP7489926B2 (ja) 中性子捕捉療法のための生分解性ナノキャリア(bpmo)およびその方法
RU2780888C2 (ru) БИОРАЗЛАГАЕМЫЙ(-МЫЕ) НАНОНОСИТЕЛЬ(-ЛИ) (BPMOs) ДЛЯ НЕЙТРОН-ЗАХВАТНОЙ ТЕРАПИИ И ЕЕ МЕТОДЫ
Wang et al. Perspectives of metal-organic framework nanosystem to overcome tumor drug resistance
Yu et al. Boron delivery systems for enhanced boron neutron capture therapy: a comprehensive review
CN100417421C (zh) 有机金属碳硼烷靶向制剂的制备方法及制成的靶向制剂

Legal Events

Date Code Title Description
D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED

Effective date: 20241122

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20241122

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20241219

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250424

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT

Effective date: 20250430

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260318